Avricore Health Inc. (TSXV: AVCR) is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab™ (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies.
Company profile
Ticker
AVCRF, AVCR
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
ALDA Pharmaceuticals Corp., NUVA Pharmaceuticals Inc., Vanc Pharmaceuticals Inc.
SEC CIK
Latest filings (excl ownership)
6-K
Current report (foreign)
6 Dec 23
6-K
Current report (foreign)
10 Oct 23
6-K
Healthtab™ Signs Reseller Agreement with Abbott to Support Uk Expansion
13 Sep 23
6-K
Current report (foreign)
3 Aug 23
6-K
Current report (foreign)
10 Jul 23
20-F
2022 FY
Annual report (foreign)
16 Jun 23
6-K
Avricore Health Corporate Updates on Audited Results for 2022
8 Jun 23
6-K
Current report (foreign)
5 May 23
6-K
Current report (foreign)
4 Apr 23
6-K
Current report (foreign)
10 Mar 23
Latest ownership filings
No filings
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |